Horst von Recum is an expert in the area of biomaterials for drug delivery, tissue engineering and regenerative medicine. One of his primary applications is the use of molecular interactions to control drug delivery rate, generating devices, which can be reloaded in vivo for multiple therapeutic windows as needed. His work has been applied toward hernia repair, incontinence, cardiovascular disease, cancer, HIV, and implant infection. He formed a successful startup company, Affinity Therapeutics. Von Recum's PhD and postdoc trainees have gone on to positions in academia, industry and the government.
- Horst Von Recum, PhD
- Institution: Case Western Reserve University
- Professor of Biomedical Engineering
- Research Interests: Biomaterials for drug delivery, tissue engineering and regenerative medicine